Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Clinical Trials
Return to: PBR Home | Contract Research & Services | Clinical Trials | Suppliers

Penn Pharma - Drug Development, Clinical Supplies & Contract Manufacturing Solutions

Penn Pharma is a leading provider of fully integrated and cost effective pharmaceutical development, clinical supply and manufacturing and packing services to the international healthcare industry, whose services support a fast and effective route from clinic to market. Penn provides unparalleled service offerings developed over its 30 year trading history.

Penn Pharma is committed to improving the health and quality of life for patients around the world through its support of the development of new medicines and devices.

Our aim is to provide solutions and challenge in a consultative way to identify and predict hurdles before they are reached, to help our customers succeed. To achieve this we demonstrate passion, energy and commitment to our task which facilitates speed of customers' products to market. Outstanding customer care is Penn Pharma's primary goal and we continually strive for excellence in all our processes.

Pharmaceutical development and drug product manufacturing services

Penn Pharma provides pharmaceutical development and drug product manufacturing services to the European and international health care industry. Penn Pharma’s services support a fast and effective route from early human clinical trials through later phases to commercialisation of medicinal products. Our customers range from virtual pharmaceutical companies, who own intellectual property (IP) but have no operational capabilities through small and medium pharma and contract research organisations (CRO’s) to the top 50 pharmaceutical companies.

We believe our service offerings are unparalleled, because Penn Pharma has 5 core competencies which support both clinical and commercial product development and supply. Here, clinical is defined as drugs in phases I through phase lll human clinical trials and commercial is defined as phase lV post approval, unlicensed medicines (Specials) and products holding Marketing Authorisations (MAs).

Pharmaceutical service solutions

From its fully integrated operations in South Wales, UK, Penn's core services include:

  • Formulation development
  • Analytical services
  • Clinical Trial Supply – Phase I – IV packing and labelling, including FastTrack™
  • Clinical Trial Manufacturing including highly potent molecules
  • Logistics - storage, distribution, returns, destruction and inventory management of clinical and commercial materials including support management of Investigator Sponsored Studies
  • Specialised manufacturing, from pilot to commercial batch sizes
  • Manufacture of specials (unlicensed medicines)
  • Qualified person (QP) release services
  • Importation of clinical and commercial products into EU through our PharmacEUtical Portal™ service

MHRA regulated and FDA inspected facility

Our fully integrated GMP compliant facilities meet the highest quality and regulatory standards, are licensed by the MHRA and are regularly inspected by the FDA. Penn Pharma is also licensed by the UK Home Office for importation and storage of controlled drugs.

Penn has numerous industry recognised awards including two Queen's Awards for Enterprise in recognition of the quality service we provide to the international healthcare industry.

Penn Pharmaceutical Services Ltd
23-24 Tafarnaubach Industrial Estate
Tredegar
Gwent, South Wales
NP22 3AA
United Kingdom

Tel: +44 (0) 1495 711 222
Fax: +44 (0) 1495 711 225
enquiries@pennpharm.com
www.pennpharm.com